{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:00:18Z","timestamp":1777449618908,"version":"3.51.4"},"reference-count":24,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Altern Lab Anim"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:p>This response on behalf of FRAME to the European Commission's consultation on the five chapters of the Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects \u2014 2010, is via a Comment in ATLA, rather than via the template supplied by the Commission. This is principally so that a number of general points about cosmetic ingredient testing can be made. It is concluded that the five draft chapters do not provide a credible basis for the Commission's forthcoming report to the European Parliament and the European Council on the five cosmetic ingredient safety issues for which the 7th Amendment to the Cosmetic Directive's ban on animal testing was postponed until 2013. This is mainly because there is insufficient focus in the draft chapters on the specific nature of cosmetic ingredients, their uses, their local effects and metabolism at their sites of application, and, in particular, on whether their possible absorption into the body would be likely to lead to their accumulation in target sites at levels approaching Thresholds of Toxicological Concern. Meanwhile, there continues to be uncertainty about how the provisions of the Cosmetics Directive should be applied, given the requirements of the REACH system and directives concerned with the safety of other chemicals and products.<\/jats:p>","DOI":"10.1177\/026119291003800502","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T04:49:22Z","timestamp":1554785362000},"page":"345-353","source":"Crossref","is-referenced-by-count":8,"title":["A Frame Response to the European Commission Consultation on the\n                    <i>Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects \u2014 2010<\/i>"],"prefix":"10.1177","volume":"38","author":[{"given":"Michael","family":"Balls","sequence":"first","affiliation":[{"name":"Fund for the Replacement of Animals in Medical Experiments (FRAME), Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Clothier","sequence":"additional","affiliation":[{"name":"Fund for the Replacement of Animals in Medical Experiments (FRAME), Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2010,10,1]]},"reference":[{"key":"bibr1-026119291003800502","unstructured":"Anon. (2004). Guidance Document on the Demarcation between the Cosmetic Products Directive 76\/768 and the Medical Products Directive 2001\/83 as agreed between the Commission Services and the Competent Authorities of the Member States. 11pp. Brussels, Belgium: European Commission."},{"key":"bibr2-026119291003800502","unstructured":"OECD (2004). OECD Guidelines for the Testing of Chemicals. Section 4: Health Effects, No. 427. Skin Absorption: In Vivo Method, 8pp. Paris, France: OECD. Available at: http:\/\/titania.sourceoecd.org\/vl=7565018\/cl=29\/nw=1\/rpsv\/cw\/vhosts\/oecdjournals\/1607310x\/v1n4\/contp1-1.htm (Accessed 30.09.10)."},{"key":"bibr3-026119291003800502","unstructured":"OECD (2004). OECD Guidelines for the Testing of Chemicals. Section 4: Health Effects, No. 428. Skin Absorption: In Vitro Method, 8pp. Paris, France: OECD. Available at: http:\/\/titania.sourceoecd.org\/vl=7565018\/cl=29\/nw=1\/rpsv\/cw\/vhosts\/oecdjournals\/1607310x\/v1n4\/contp1-1.htm (Accessed 30.09.10)."},{"key":"bibr4-026119291003800502","first-page":"595","volume":"37","author":"Carmichael P.","year":"2009","journal-title":"ATLA"},{"key":"bibr5-026119291003800502","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0043fje"},{"key":"bibr6-026119291003800502","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2004.10.005"},{"key":"bibr7-026119291003800502","first-page":"859","volume":"24","author":"Clothier R.","year":"1996","journal-title":"ATLA"},{"key":"bibr8-026119291003800502","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-2333(97)00083-0"},{"key":"bibr9-026119291003800502","first-page":"91","volume":"32","author":"Gray A.C.","year":"2004","journal-title":"ATLA"},{"key":"bibr10-026119291003800502","first-page":"493","volume":"35","author":"Gray A.C.","year":"2007","journal-title":"ATLA"},{"key":"bibr11-026119291003800502","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024492725782"},{"key":"bibr12-026119291003800502","first-page":"275","volume":"38","author":"Ashikaga T.","year":"2010","journal-title":"ATLA"},{"key":"bibr13-026119291003800502","first-page":"19","volume":"34","author":"Knight A.","year":"2006","journal-title":"ATLA"},{"key":"bibr14-026119291003800502","first-page":"29","volume":"34","author":"Knight A.","year":"2006","journal-title":"ATLA"},{"key":"bibr15-026119291003800502","unstructured":"OECD (2004). OECD Guidelines for the Testing of Chemicals. Section 4: Health Effects, No. 414. Prenatal Development Toxicity Study, 11pp. Paris, France: OECD. Available at: http:\/\/titania.sourceoecd.org\/vl=7565018\/cl=29\/nw=1\/rpsv\/cw\/vhosts\/oecdjournals\/1607310x\/v1n4\/contp1-1.htm (Accessed 30.09.10)."},{"key":"bibr16-026119291003800502","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2010.05.007"},{"key":"bibr17-026119291003800502","first-page":"635","volume":"36","author":"Hartung T.","year":"2008","journal-title":"ATLA"},{"key":"bibr18-026119291003800502","doi-asserted-by":"publisher","DOI":"10.1038\/4601080a"},{"key":"bibr19-026119291003800502","first-page":"365","volume":"34","author":"Spielmann H.","year":"2006","journal-title":"ATLA"},{"key":"bibr20-026119291003800502","first-page":"1","volume":"35","author":"Combes R.","year":"2007","journal-title":"ATLA"},{"key":"bibr21-026119291003800502","unstructured":"SchaeferC., SpielmannH. & VetterK. (2006). Arzneiverordnung in Schwangerschaft und Stillzeit, 781pp. Jena, Germany: Urban & Fischer."},{"key":"bibr22-026119291003800502","doi-asserted-by":"publisher","DOI":"10.2174\/138161207782110462"},{"key":"bibr23-026119291003800502","doi-asserted-by":"publisher","DOI":"10.1163\/1569391053722755"},{"key":"bibr24-026119291003800502","first-page":"641","volume":"37","author":"Spielmann H.","year":"2009","journal-title":"ATLA"}],"container-title":["Alternatives to Laboratory Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026119291003800502","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026119291003800502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:41:28Z","timestamp":1777380088000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/026119291003800502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1177\/026119291003800502"],"URL":"https:\/\/doi.org\/10.1177\/026119291003800502","relation":{},"ISSN":["0261-1929","2632-3559"],"issn-type":[{"value":"0261-1929","type":"print"},{"value":"2632-3559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}